Cell>Point to expedite research on new drugs as potentially effective theranostic technology in fight against COVID-19
CENTENNIAL -- CellPoint announced plans to move forward with a research program to clinically develop 99m Tc-EC-Amifostine and 177 Lu-EC-Amifostine to assess, treat and follow-up with confirmatory... Read More
Wednesday March 25, 2020
Cell>Point moves ahead with new cancer drugs
CENTENNIAL -- CellPoint announced it is moving forward with two intra-nuclear therapeutics to more effectively target cancer cells with minimal damage to adjacent healthy cells. The company... Read More
Friday January 24, 2020
IN Sponsors
Browse
Entrepreneurial by Nature
